OncoMed Pharma (OMED) Announces Presentation of Positive Ipafricept Combo Phase 1b Data at ESMO 2016
Tweet Send to a Friend
OncoMed Pharmaceuticals Inc. (Nasdq: OMED) announced the presentation of interim clinical data from its ongoing Phase 1b trials of ipafricept ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
